… postprandial hyperglycemia in patients with type 2 diabetes already on basal insulin therapy: R eview of current strategies: 改善既往已在使用基础胰岛素治疗的2 型 …
GE Umpierrez, TS Bailey, D Carcia… - … of Diabetes, 2018 - Wiley Online Library
… 6 trial61 assessed the cardiovascular safety of semaglutide, an investigational … cardiovascular
outcomes trials have shown no link between some DPP-4 inhibitors and CVD in patients …
outcomes trials have shown no link between some DPP-4 inhibitors and CVD in patients …
… glycemic control on the Diabetes Complications Severity Index score and development of complications in people with newly diagnosed type 2 diabetes: 在新诊断的2 …
KM Pantalone, AD Misra‐Hebert, TM Hobbs… - … of diabetes, 2018 - Wiley Online Library
… In the semaglutide cardiovascular outcome trial, the rates of new or worsening
nephropathy were lower in the semaglutide group, but rates of retinopathy complications (vitreous …
nephropathy were lower in the semaglutide group, but rates of retinopathy complications (vitreous …
[HTML][HTML] 司美格鲁肽对肥胖2 型糖尿病患者皮肤微循环功能的影响
李锦亮， 曾茂娟， 钟金宝… - 中华肥胖与代谢病 …, 2023 - zhfpydxbdzzz.cma-cmc.com.cn
… Effect of semaglutide on skin microcirculatory function in obese patients with type 2 diabetes
mellitus[J]. Chinese Journal of Obesity and Metabolic Diseases(Electronic Edition), 2023, 09…
mellitus[J]. Chinese Journal of Obesity and Metabolic Diseases(Electronic Edition), 2023, 09…
[PDF][PDF] 第二型糖尿病患者的心血管疾病照護
KK Ray - biomedicine.org.tw
… 另外一種新機轉 的GLP-1 receptor antagonist 藥品Liraglutide, Semaglutide 也在臨床試驗中…
clinical outcomes in patients with type 2 diabetes mellitus, established cardiovascular disease…
clinical outcomes in patients with type 2 diabetes mellitus, established cardiovascular disease…
[PDF][PDF] SGLT-2 抑制剂及GLP-1 受体激动剂治疗2 型糖尿病的心血管获益: 一项系统回顾和网状Meta 分析
赖彦岚， 黄爱文， 陈官旭， 陈婷婷， 赵丽君， 廖小兰… - 药学实践 …, 2022 - yxsj.smmu.edu.cn
… , dapagliflozin, exenatide, liraglutide and oral semaglutide reduced the incidence of all-cause …
, liraglutide and oral semaglutide can reduce the risk of cardiovascular death events, with …
, liraglutide and oral semaglutide can reduce the risk of cardiovascular death events, with …
[HTML][HTML] 中医防治司美格鲁肽治疗2 型糖尿病引起功能性消化不良的研究进展
刘莹莹， 任延明 - Traditional Chinese Medicine, 2024 - hanspub.org
… Semaglutide in the treatment of type 2 diabetes … Semaglutide in the treatment of type 2
diabetes mellitus, and provides help for the treatment of type 2 diabetes mellitus with Semaglutide. …
diabetes mellitus, and provides help for the treatment of type 2 diabetes mellitus with Semaglutide. …
[PDF][PDF] 人胰高血糖素样肽-1 受体激动剂索马鲁肽的研究进展
阮江雄， 谢丽萍， 胡又佳 - 世界临床药物, 2018 - jwph.com.cn
… posthoc analysis of the effect of semaglutide on cardiovascular outcomes over time in subjects
with type 2 diabetes[J]. Can J … Semaglutide and cardiovascular outcomes in patients with …
with type 2 diabetes[J]. Can J … Semaglutide and cardiovascular outcomes in patients with …
2 型糖尿病患者中肠促胰素药物与胰腺癌风险: 一项随机对照试验的Meta 分析.
田勍， 刘烨， 路然， 杨进， 王海宁… - … Journal of Diabetes …, 2017 - search.ebscohost.com
… of sitagliptin on cardiovascular outcomes in type 2 diabetes[J]… over 1 year in people with
type 2 diabetes currently taking … exenatide on cardiovascular outcomes in type 2 diabetes[J]. …
type 2 diabetes currently taking … exenatide on cardiovascular outcomes in type 2 diabetes[J]. …
GLP-1 受体激动剂/类似物治疗2 型糖尿病的研究进展.
张宁倩， 王清 - Practical Pharmacy & Clinical Remedies, 2019 - search.ebscohost.com
… 次数 并且维持一定的血药浓度ꎬ目前最长可应用1 周注射1次 的剂型ꎬ但受到价格及患者耐受
程度等多方面影响ꎬ患者依 从性仍较差ꎬ这时对口服制剂的需求就更迫切ꎬ 目前ꎬ Semaglutide的…
程度等多方面影响ꎬ患者依 从性仍较差ꎬ这时对口服制剂的需求就更迫切ꎬ 目前ꎬ Semaglutide的…
司美格鲁肽注射液联合依折麦布片治疗2 型糖尿病合并冠心病心绞痛的疗效研究.
武芳芳， 陈雪， 吴昊， 赵健… - … & Analysis of Drug-Use in …, 2023 - search.ebscohost.com
… probe into the effects of semaglutide injection combined with … of type 2 diabetes mellitus
complicated with coronary heart … semaglutide once weekly in patients with type 2 diabetes[J]. …
complicated with coronary heart … semaglutide once weekly in patients with type 2 diabetes[J]. …